TERT-BUTYL ((3-METHYLAZETIDIN-3-YL)METHYL)CARBAMATE, 95.0%, 1g

8-Chloropyrido[2,3-b]pyrazine, 95.0%, 1g

4-Amino-3-chloro-5-fluorobenzonitrile, 95.0%, 1g

Glass syringe with Luer connection (glass), 2 ml, 1 piece

2,7-Dimethylnaphthalene>98.0%(GC)5g

TERT-BUTYL 6-HYDROXY-5-METHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXYLATE, 95.0%, 1g

2'-(tert-Butyl(phenyl)phosphino)-N2,N2,N6,N6-tetramethyl-[1,1'-biphenyl]-2,6-diamine, 98%, 250mg

Methyl 4-bromo-6-methylnicotinate, 95.0%, 25g

4-Methoxyphenyl 3-O-Allyl-beta-D-galactopyranoside>98.0%(HPLC)5g

2-(Di-tert-butylphosphino)biphenyl>98.0%(GC)5g

2,6-Dimethylpiperazine, 95.0%, 10g

TERT-BUTYL 2-CYCLOPROPYLHYDRAZINECARBOXYLATE, 95.0%, 250mg

Heptane (isomers), min. 98.5%, for synthesis, 10 l, whitbl.